Cargando…

Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro

BACKGROUND: Tumour resistance to a wide range of drugs (multiple drug resistant, MDR) acquired after intensive chemotherapy is considered to be the main obstacle of the curative treatment of cancer patients. Recent work has shown that oncolytic viruses demonstrated prominent potential for effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goncharova, Elena P., Ruzhenkova, Julia S., Petrov, Ivan S., Shchelkunov, Sergey N., Zenkova, Marina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989492/ https://www.ncbi.nlm.nih.gov/pubmed/27538520 http://dx.doi.org/10.1186/s12967-016-1002-x

Ejemplares similares

Erratum to: Oncolytic virus efficiency inhibited growth of tumour cells with multiple drug resistant phenotype in vivo and in vitro
por: Goncharova, Elena P., et al.
Publicado: (2016)

A Novel Sulfonated Derivative of β-Cyclodextrin Effectively Inhibits Influenza A Virus Infection in vitro and in vivo
por: Goncharova, E. P., et al.
Publicado: (2019)

The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo
por: Anesti, Anna-Maria, et al.
Publicado: (2010)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

Oncolytic adenovirus armed with IL-24 Inhibits the growth of breast cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2012)

Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives
por: McKenna, Mary K., et al.
Publicado: (2020)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
por: Ghose, Jayeeta, et al.
Publicado: (2021)

Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018)

Female Scent Signals Enhance the Resistance of Male Mice to Influenza
por: Litvinova, Ekaterina A., et al.
Publicado: (2010)

Oncolytic viruses & their specific targeting to tumour cells
por: Singh, Prafull K., et al.
Publicado: (2012)

Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo
por: Doerner, Johannes, et al.
Publicado: (2022)

Oncolytic Virotherapy of Canine and Feline Cancer
por: Gentschev, Ivaylo, et al.
Publicado: (2014)

Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice
por: Martikainen, Miika, et al.
Publicado: (2017)

Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
por: Tang, Tianyu, et al.
Publicado: (2022)

Inactivation of the tick-borne encephalitis virus by RNA-cleaving compounds
por: Goncharova, Elena P, et al.
Publicado: (2011)

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
por: Akram, Sura, et al.
Publicado: (2023)

Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo
por: Shen, Wei, et al.
Publicado: (2009)

MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2013)

Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
por: Evgin, Laura, et al.
Publicado: (2021)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
por: Marchica, Valentina, et al.
Publicado: (2021)

Antitumor effects of a dual cancer-specific oncolytic adenovirus on colorectal cancer in vitro and in vivo
por: YANG, GUOHUA, et al.
Publicado: (2015)

Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo
por: Wang, Jing, et al.
Publicado: (2022)

Bluetongue Viruses Act as Novel Oncolytic Viruses to Effectively Inhibit Human Renal Cancer Cell Growth In Vitro and In Vivo
por: Wang, Haozhou, et al.
Publicado: (2021)

The Effects of Oncolytic Pseudorabies Virus Vaccine Strain Inhibited the Growth of Colorectal Cancer HCT-8 Cells In Vitro and In Vivo
por: Chai, Chunxia, et al.
Publicado: (2022)

In vivo-in vitro clonogenic assays in a human tumour xenograft with a high plating efficiency.
por: Warenius, H. M., et al.
Publicado: (1982)

Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
por: Markov, Oleg V., et al.
Publicado: (2015)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo
por: Mohamed, Islam Saber Ead, et al.
Publicado: (2022)

Tumour-specific triple-regulated oncolytic herpes virus to target glioma
por: Delwar, Zahid M., et al.
Publicado: (2016)

Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity
por: Teijeira Crespo, Alicia, et al.
Publicado: (2021)

HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro
por: Wang, Fuli, et al.
Publicado: (2008)

Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
por: Hajri, A., et al.
Publicado: (1998)

Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo
por: Xiao, Li, et al.
Publicado: (2010)

CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo
por: Li, G, et al.
Publicado: (2014)

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014)

Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
por: Yin, Lei, et al.
Publicado: (2017)

Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo
por: Fan, Jingjing, et al.
Publicado: (2021)

Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo
por: Schwertner, Barbara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6tpl7m2j8mh7erop6b9opsvsft